Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 17/20 | 0.61 |
| ▸ | HTR2C | P28335 | 13/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4037589 | 0.91 | HTR2A (0.67) | HTR2AHTR2CMAPT | |
| SCHEMBL14385122 | 0.88 | HTR2A (0.64) | HTR2AHTR2CKCNH2 | |
| SCHEMBL4039931 | 0.88 | HTR2A (0.66) | HTR2AHTR2CMAPT | |
| SCHEMBL4565514 | 0.87 | HTR2A (0.65) | HTR2AHTR2CKCNH2 | |
| SCHEMBL3949991 | 0.86 | HTR2A (0.68) | HTR2AHTR2CKCNH2 | |
| SCHEMBL4035181 | 0.86 | HTR2A (0.68) | HTR2AHTR2CKCNH2 | |
| SCHEMBL4046566 | 0.83 | HTR2A (0.56) | HTR2AHTR2CMAPTKMT2AKCNH2 | |
| SCHEMBL4045085 | 0.83 | HTR2A (0.73) | HTR2AHTR2CKCNH2 | |
| SCHEMBL3947503 | 0.81 | HTR2A (0.81) | HTR2AHTR2C | |
| SCHEMBL4043358 | 0.80 | HTR2A (0.72) | HTR2AHTR2CMAPTKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2051978-A2 | ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2009-04-29 | — | — | EP | claimed |
| WO-2007136875-A2 | ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2007-11-29 | — | — | WO | claimed |
| EP-2070093-A1 | FUNCTIONAL GRAPHENE-RUBBER NANOCOMPOSITES | The Trustees of Princeton University (US) | 2009-06-17 | — | — | EP | disclosed |
| EP-2051978-A2 | ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2009-04-29 | — | — | EP | disclosed |
| WO-2008045778-A1 | FUNCTIONAL GRAPHENE-RUBBER NANOCOMPOSITES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2008-04-17 | — | — | WO | disclosed |
| WO-2007136875-A2 | ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2007-11-29 | — | — | WO | disclosed |